Lipocine (LPCN) EV to EBIT (2021 - 2022)
Lipocine's (LPCN) EV to EBIT was 1.73 for Q3 2022, down 86.6% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) EV to EBIT (2021 - 2022) Analysis & Trends
Over the twelve months ended Sep 30, 2022, Lipocine's EV to EBIT came in at -36.72; for FY2021, it was 13.63.
- Per Business Quant data, the three quarters before Q3 2022 came in at 12.93 (Q2 2022), 25.33 (Q1 2022) and 13.63 (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 1.73 |
| Jun 30, 2022 | 12.93 |
| Mar 31, 2022 | 25.33 |
| Dec 31, 2021 | 13.63 |
API Access
Lipocine EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();